Skip to main content
Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
13.42
-0.26 (-1.90%)
Aug 14, 2025, 4:31 PM CET

SWX:SANN Revenue

In the year 2024, Santhera Pharmaceuticals Holding AG had annual revenue of 39.12M CHF, down -62.17%. Santhera Pharmaceuticals Holding AG had revenue of 25.00M in the half year ending December 31, 2024, with 1,944.40% growth.

Revenue
39.12M
Revenue Growth
-62.17%
P/S Ratio
4.50
Revenue / Employee
495.15K
Employees
79
Market Cap
176.08M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202439.12M-64.30M-62.17%
Dec 31, 2023103.41M95.94M1,283.84%
Dec 31, 20227.47M9.07M-568.53%
Dec 31, 2021-1.60M-16.60M-110.63%
Dec 31, 202015.01M-60.37M-80.09%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Roche Holding AG 63.49B
Novartis AG 43.89B
Lonza Group AG 7.09B
Alcon 8.77B
Galderma Group AG 3.73B
Sandoz Group AG 8.42B
Straumann Holding AG 2.50B
Sonova Holding AG 3.87B
Revenue Rankings

Santhera Pharmaceuticals Holding AG News

More News